Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Fisher & Paykel Healthcare Confirms No Material Impact on Earnings Guidance

21 Feb 2019  |  07:38:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: FPH Confirms no Material Impact on Earnings Guidance

Fisher & Paykel Healthcare announced that settlement of the global patent infringement litigation with ResMed will not have a material impact on its net profit after tax guidance for the 2019 financial year. The Company provided earnings guidance in an announcement to the market on 26 November 2018 and it expects no material impact to that guidance given the proximity of the settlement to the end of the Company's financial year and the legal fees expected to be incurred to withdraw the pending infringement cases.

Please click here for full details

See more ASX300 News Announcements